SAKAR Healthcare Limited reported a strong year-on-year performance for the quarter ended 31 December 2025, supported by higher revenue and improved profitability compared with the same quarter last year.
SAKAR Healthcare Q3 Revenue Performance (YoY)
Revenue from operations for Q3 stood at Rs 70.34 crore, compared with Rs 43.42 crore in Q3 FY25. This translates into a YoY growth of 62.02%, indicating a sharp expansion in operational scale during the quarter.
Total income for the quarter came in at Rs 70.85 crore, up from Rs 43.71 crore in the year-ago period, registering a YoY increase of 62.03%. Other income remained relatively small and did not materially impact overall income growth.
SAKAR Healthcare Q3 Expenses Trend
Total expenses during Q3 rose to Rs 59.90 crore, compared with Rs 38.19 crore in Q3 FY25, reflecting a YoY increase of 56.84%.
The rise in costs was primarily driven by higher raw material consumption and employee benefit expenses, in line with increased operational activity.
Despite the increase in expenses, income growth outpaced cost growth, resulting in improved profitability.
SAKAR Healthcare Q3 Profit Before Tax (PBT)
Profit before tax for the quarter stood at Rs 10.95 crore, nearly doubling from Rs 5.48 crore in the corresponding quarter last year. This marks a YoY growth of 99.99%.
PBT margin improved to 15.46% in Q3 FY26, compared with 12.53% in Q3 FY25, reflecting better operating leverage.
SAKAR Healthcare Q3 Net Profit (PAT)
Profit after tax from continuing operations came in at Rs 10.25 crore, compared with Rs 4.53 crore in Q3 FY25. This represents a YoY jump of 126.12%.